Press Releases

Governor of State of Hawaii

STATE OF HAWAIʻI KA MOKU ʻĀINA O HAWAIʻI JOSH GREEN, M.D. GOVERNOR KE KIAʻĀINA DEPARTMENT OF HEALTH KA ʻOIHANA OLAKINO KENNETH S. FINK, M.D., MGA, MPH DIRECTOR KA LUNA HOʻOKELE DOH RECRUITS TEEN HEALTH AND MEDIA SURVEY PARTICIPANTS VIA MAIL 26-052...

GlobeNewswire, Inc.

Invivyd authors evaluated early side effects of prior low-dose investigational monoclonal antibody adintrevimab from the EVADE study, demonstrating minimal tolerability issues Results allow for comparison to contemporary COVID-19 mRNA and protein...

GlobeNewswire, Inc.

– Peer-reviewed study from the bioMUSE Natural History Study shows advanced MRI method detects disease-specific iron accumulation that supports diagnosis and correlates with clinical severity in patients with Multiple System Atrophy (MSA) – –...

EIN Presswire

SLIDELL, LA, UNITED STATES, May 8, 2026 /⁨EINPresswire.com⁩/ -- Attention Deficit Disorder, commonly referred to as ADD or ADHD inattentive type, affects both children and adults across a wide range of environments including school, work,...

GlobeNewswire, Inc.

Presented positive Phase 3 HAELO topline clinical data for lonvo-z in HAE; initiated rolling BLA submission; anticipate U.S. launch in first half of 2027 Recently resumed patient screening in MAGNITUDE and MAGNITUDE-2 Phase 3 clinical trials of...

U.S. Food and Drug Administration

COMPANY ANNOUNCEMENT When a company announces a recall, market withdrawal, or safety alert, the FDA posts the company's announcement as a public service.

U.S. Food and Drug Administration

COMPANY ANNOUNCEMENT When a company announces a recall, market withdrawal, or safety alert, the FDA posts the company's announcement as a public service.

EIN Presswire

About You Family Medicine expands to Midtown Atlanta, offering membership-based direct primary care with longer visits and transparent pricing.

EIN Presswire

LOS ANGELES, CA, UNITED STATES, May 8, 2026 /⁨EINPresswire.com⁩/ -- Clarity Family Therapy Services, a trusted provider of compassionate mental health care, announces the expansion of its innovative therapy programs tailored for Los Angeles...

GlobeNewswire, Inc.

Durham, N.C., May 11, 2026 (GLOBE NEWSWIRE) -- AB-1009, an adeno-associated virus (AAV) investigational gene therapy, is being evaluated for the treatment of late-onset Pompe disease (LOPD) in the PROGRESS-GT LOPD trial AskBio initiated...

GlobeNewswire, Inc.

LEIDEN, Netherlands & CAMBRIDGE, Mass., May 11, 2026 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq: PRQR) (ProQR), a clinical-stage company dedicated to changing lives through transformative RNA therapies based on its proprietary Axiomer™...

Government of Saskatchewan

CANADA, May 8 - Released on May 8, 2026 Today, the Government of Saskatchewan and Saskatchewan Health Authority (SHA) launched new, patient-friendly enhancements to the SHA website, allowing citizens to easily find and access information about...

GlobeNewswire, Inc.

4basebio PLC ("4basebio" or the "Company") 4basebio Launches Enzymatic ssDNA Platform Overcomes critical manufacturing and performance bottlenecks associated with traditional chemical synthesis, providing faster and more reliable ssDNA...

Mesa County Government - Colorado

Mesa County is continuing efforts to address substance use and mental health needs within the local jail system.

The Government of Prince Edward Island

CANADA, May 8 - Verifying your browser before proceeding...

EIN Presswire

Not a single company leave policy reviewed over two years references menstrual health, even as one in four now covers fertility and prenatal care.

GlobeNewswire, Inc.

- Interim results from the first three brain cancer patients treated; two of whom demonstrated complete response, with total disappearance of all enhancing tumor lesions, per multiple MRI scans since treatment - - One associated grade 3 serious...

GlobeNewswire, Inc.

Erdem Health Group has been accepted into TURQUALITY®, Türkiye’s state-backed brand development program.

GlobeNewswire, Inc.

NORCROSS, Ga., May 11, 2026 (GLOBE NEWSWIRE) -- Galectin Therapeutics Inc. (NASDAQ:GALT), a clinical-stage biotechnology company developing therapeutics that target galectin-3 for patients with MASH cirrhosis and portal hypertension, today...

GlobeNewswire, Inc.

Rebar will focus on establishing a pipeline of in vivo CAR T therapeutic programs based on the company’s proprietary immune-quiet DNA vector platform David Maier appointed to expanded role as CPTx Chief Business Officer Munich, Germany & San...